SEOM化疗所致恶心和呕吐预防临床指南更新（2016年）
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016).
作者信息
de Las Peñas R, Blasco A, De Castro J, Escobar Y, García-Campelo R, Gúrpide A, Lopez-Lopez R, Majem M, Rodríguez C A, Virizuela J A
机构信息
Servicio de Oncología Médica, Consorcio Hospital Provincial de Castellón, Avda. Dr. Clará, 19, 12002, Castellón de la Plana, Castellón, Spain.
Servicio de Oncología Médica, Hospital General Universitario de Valencia, Valencia, Spain.
出版信息
Clin Transl Oncol. 2016 Dec;18(12):1237-1242. doi: 10.1007/s12094-016-1583-0. Epub 2016 Nov 28.
Abstract
Chemotherapy-induced nausea and vomiting is one of the most worrisome adverse effects of chemotherapy for cancer patients. It can cause severe discomfort and affect the quality of life. In recent years, the incorporation of new drugs has increased the efficacy of antiemetic treatments in the control of emesis associated with chemotherapy. This guideline, in which we give some treatment recommendations with level of evidence and grade of recommendation, provides an update of the previously published guideline of the Spanish Society of Medical Oncology and represents our continued commitment to improving supportive care in cancer patients.
摘要
化疗引起的恶心和呕吐是癌症患者化疗最令人担忧的不良反应之一。它会导致严重不适并影响生活质量。近年来，新药的加入提高了止吐治疗在控制化疗相关呕吐方面的疗效。本指南给出了一些具有证据水平和推荐等级的治疗建议，是对西班牙医学肿瘤学会之前发布的指南的更新，体现了我们持续致力于改善癌症患者支持性护理的承诺。
相似文献
1
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016).SEOM化疗所致恶心和呕吐预防临床指南更新（2016年）
Clin Transl Oncol. 2016 Dec;18(12):1237-1242. doi: 10.1007/s12094-016-1583-0. Epub 2016 Nov 28.
2
A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.对一家三级护理中心儿科肿瘤患者化疗引起的恶心和呕吐的止吐药使用情况进行回顾性研究。
J Oncol Pharm Pract. 2013 Jun;19(2):138-44. doi: 10.1177/1078155212457966. Epub 2012 Oct 3.
3
SEOM clinical guidelines for the treatment of antiemetic prophylaxis in cancer patients receiving chemotherapy.SEOM 临床指南：癌症患者化疗时止吐预防的治疗。
Clin Transl Oncol. 2010 Nov;12(11):770-4. doi: 10.1007/s12094-010-0594-5.
4
2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.2016年更新的MASCC/ESMO共识建议：控制低致吐或极低致吐风险化疗引起的恶心和呕吐
Support Care Cancer. 2017 Jan;25(1):297-301. doi: 10.1007/s00520-016-3391-z. Epub 2016 Aug 30.
5
SEOM clinical guideline emesis (2021).SEOM 临床指南：呕吐（2021）。
Clin Transl Oncol. 2022 Apr;24(4):712-723. doi: 10.1007/s12094-022-02802-1. Epub 2022 Mar 26.
6
The safety of antiemetic medications for the prevention of chemotherapy-induced nausea and vomiting.用于预防化疗引起的恶心和呕吐的止吐药物的安全性。
Expert Opin Drug Saf. 2016;15(3):343-56. doi: 10.1517/14740338.2016.1135899. Epub 2016 Jan 14.
7
Treatment of breakthrough and prevention of refractory chemotherapy-induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update.儿科癌症患者突破性和难治性化疗引起的恶心和呕吐的治疗：临床实践指南更新。
Pediatr Blood Cancer. 2023 Aug;70(8):e30395. doi: 10.1002/pbc.30395. Epub 2023 May 13.
8
Latest Update on Prevention of Acute Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer Patients.儿科癌症患者化疗所致急性恶心呕吐的最新预防措施。
Curr Oncol Rep. 2019 Aug 15;21(10):89. doi: 10.1007/s11912-019-0840-0.
9
Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study.意大利癌症中心化疗引起的恶心和呕吐：一项前瞻性多中心研究CINVDAY的结果
Tumori. 2014 Nov-Dec;100(6):e309-13. doi: 10.1700/1778.19310.
10
Changes in Antiemetic Overuse in Response to Choosing Wisely Recommendations.止吐药滥用的变化对“明智选择”建议的响应。
JAMA Oncol. 2017 Mar 1;3(3):320-326. doi: 10.1001/jamaoncol.2016.2530.
引用本文的文献
1
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting.2023 MASCC 和 ESMO 指南更新：预防化疗和放疗引起的恶心和呕吐。
ESMO Open. 2024 Feb;9(2):102195. doi: 10.1016/j.esmoop.2023.102195. Epub 2024 Jan 11.
2
2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.2023 更新 MASCC/ESMO 共识建议：用低致吐性或轻微致吐性化疗控制恶心和呕吐。
Support Care Cancer. 2023 Dec 19;32(1):37. doi: 10.1007/s00520-023-08223-2.
3
SEOM clinical guideline emesis (2021).SEOM 临床指南：呕吐（2021）。
Clin Transl Oncol. 2022 Apr;24(4):712-723. doi: 10.1007/s12094-022-02802-1. Epub 2022 Mar 26.
4
Routes of administration, reasons for use, and approved indications of medical cannabis in oncology: a scoping review.医学大麻在肿瘤学中的给药途径、使用原因和批准适应症：范围综述。
BMC Cancer. 2022 Mar 24;22(1):319. doi: 10.1186/s12885-022-09378-7.
5
Evaluation of candidemia in epidemiology and risk factors among cancer patients in a cancer center of China: an 8-year case-control study.中国某癌症中心癌症患者念珠菌血症的流行病学及危险因素评估：一项为期8年的病例对照研究
BMC Infect Dis. 2017 Aug 3;17(1):536. doi: 10.1186/s12879-017-2636-x.
6
SEOM guidelines 2016: an update.2016年SEOM指南：更新版
Clin Transl Oncol. 2016 Dec;18(12):1161-1162. doi: 10.1007/s12094-016-1592-z.
本文引用的文献
1
2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting.2016年更新的MASCC/ESMO共识建议：预防放疗引起的恶心和呕吐。
Support Care Cancer. 2017 Jan;25(1):309-316. doi: 10.1007/s00520-016-3407-8. Epub 2016 Sep 13.
2
2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.2016年更新的MASCC/ESMO共识建议：控制低致吐或极低致吐风险化疗引起的恶心和呕吐
Support Care Cancer. 2017 Jan;25(1):297-301. doi: 10.1007/s00520-016-3391-z. Epub 2016 Aug 30.
3
MASCC/ESMO Antiemetic Guidelines: Introduction to the 2016 guideline update.MASCC/ESMO止吐指南：2016年指南更新介绍
Support Care Cancer. 2017 Jan;25(1):267-269. doi: 10.1007/s00520-016-3324-x. Epub 2016 Aug 8.
4
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting.奥氮平用于预防化疗引起的恶心和呕吐。
N Engl J Med. 2016 Jul 14;375(2):134-42. doi: 10.1056/NEJMoa1515725.
5
Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting.化疗引起的恶心和呕吐的预防性止吐治疗
N Engl J Med. 2016 Apr 7;374(14):1356-67. doi: 10.1056/NEJMra1515442.
6
Antiemetics: American Society of Clinical Oncology Focused Guideline Update.止吐药：美国临床肿瘤学会重点指南更新。
J Clin Oncol. 2016 Feb 1;34(4):381-6. doi: 10.1200/JCO.2015.64.3635. Epub 2015 Nov 2.
7
Dopamine receptor antagonists.多巴胺受体拮抗剂
Ann Palliat Med. 2012 Jul;1(2):137-42. doi: 10.3978/j.issn.2224-5820.2012.07.09.
8
Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review.近期化疗所致恶心呕吐（CINV）预防的研究进展：全面综述。
Ann Oncol. 2015 Jun;26(6):1081-1090. doi: 10.1093/annonc/mdv138. Epub 2015 Mar 9.
9
Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study.奈妥吡坦与帕洛诺司琼口服复方制剂NEPA预防高度致吐性化疗后化疗引起的恶心和呕吐的疗效及安全性：一项随机剂量范围关键研究
Ann Oncol. 2014 Jul;25(7):1340-1346. doi: 10.1093/annonc/mdu110. Epub 2014 Mar 7.
10
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy.一项随机III期研究，评估奈妥匹坦和帕洛诺司琼固定剂量组合制剂NEPA预防中度致吐性化疗后化疗引起的恶心和呕吐的疗效及安全性。
Ann Oncol. 2014 Jul;25(7):1328-1333. doi: 10.1093/annonc/mdu101. Epub 2014 Mar 5.
Zotero 插件